• Breakthrough therapies that change the balance in the treatment of cancer

plecoid-agent plecoid-agent

PLECOID™ AGENT

pipeline pipeline

PIPELINE

investors investors

INVESTORS

Pleco Therapeutics aims to extend the life span and enhance the quality of life of patients through its novel Plecoid™ therapies that dramatically increase the effectiveness of current cancer treatments. 

Our novel Plecoid™ therapies positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell, thereby improving the effectiveness of existing chemotherapy.

LATEST NEWS
Jan 16, 2024
Pleco Therapeutics receives FDA Orphan Drug Designation